» Articles » PMID: 20591912

Positive Screening and Carrier Results for the England-wide Universal Newborn Sickle Cell Screening Programme by Ethnicity and Area for 2005-07

Overview
Journal J Clin Pathol
Specialty Pathology
Date 2010 Jul 2
PMID 20591912
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: The overall aim of the new national newborn programme is to identify infants at risk of sickle cell disease to allow early detection and to minimise deaths and complications.

Methods: Universal screening for sickle cell disease was introduced in England between September 2003 and July 2006. The 13 newborn laboratories each screen between 25,000 and 110,000 babies a year using the existing dried bloodspot cards. The specified conditions to be screened for include sickle cell anaemia (Hb SS), Hb SC disease, Hb S/beta thalassaemia, Hb S/D(Punjab) and Hb S/O(Arab). Data are reported on screening results by ethnic group and geographical area.

Results: The prevalence of screen positive results across England is 1:2000. There is a 25-fold variation by geographical area. African babies make up 61% of all screen positive results despite representing only 4% of total births. Combined carrier rates vary widely by ethnicity, from 1.85 per 1000 (1:540) in 'White British' to 145 per 1000 (1:7) in 'African' babies. Refusal rates for screening show variation by ethnicity.

Conclusions: These results provide useful information both about the frequency of these conditions and the carrier state and their geographic and ethnic distribution across England. This can be used to refine counselling information and are also useful to target and plan services and public information.

Citing Articles

The many faces of sickle cell disease in children: complications in the appendicular skeleton.

De La Hoz Polo M, Hudson V, Adu J, Chakravorty S, Haque S Pediatr Radiol. 2024; 54(9):1437-1450.

PMID: 38740606 DOI: 10.1007/s00247-024-05913-9.


Ethnic differences and inequities in paediatric healthcare utilisation in the UK: a scoping review.

Zhang C, Quigley M, Bankhead C, Bentley T, Otasowie C, Carson C Arch Dis Child. 2022; 108(7):518-524.

PMID: 36344215 PMC: 10313970. DOI: 10.1136/archdischild-2022-324577.


Health services use by children identified as heterozygous hemoglobinopathy mutation carriers via newborn screening.

Khangura S, Potter B, Davies C, Ducharme R, Bota A, Hawken S BMC Pediatr. 2021; 21(1):296.

PMID: 34210267 PMC: 8247172. DOI: 10.1186/s12887-021-02751-8.


Anaesthetic management of children with sickle cell disease.

Akrimi S, Simiyu V BJA Educ. 2021; 18(11):331-336.

PMID: 33456798 PMC: 7807928. DOI: 10.1016/j.bjae.2018.08.003.


Sleep-disordered breathing and comorbidities: role of the upper airway and craniofacial skeleton.

Brennan L, Kirkham F, Gavlak J Nat Sci Sleep. 2020; 12:907-936.

PMID: 33204196 PMC: 7667585. DOI: 10.2147/NSS.S146608.


References
1.
Mantikou E, Arkesteijn S, Beckhoven van J, Kerkhoffs J, Harteveld C, Giordano P . A brief review on newborn screening methods for hemoglobinopathies and preliminary results selecting beta thalassemia carriers at birth by quantitative estimation of the HbA fraction. Clin Biochem. 2009; 42(18):1780-5. DOI: 10.1016/j.clinbiochem.2009.08.018. View

2.
Kai J, Ulph F, Cullinan T, Qureshi N . Communication of carrier status information following universal newborn screening for sickle cell disorders and cystic fibrosis: qualitative study of experience and practice. Health Technol Assess. 2009; 13(57):1-82, iii. DOI: 10.3310/hta13570. View

3.
Kark J, Posey D, Schumacher H, Ruehle C . Sickle-cell trait as a risk factor for sudden death in physical training. N Engl J Med. 1987; 317(13):781-7. DOI: 10.1056/NEJM198709243171301. View

4.
Streetly A, Latinovic R, Hall K, Henthorn J . Implementation of universal newborn bloodspot screening for sickle cell disease and other clinically significant haemoglobinopathies in England: screening results for 2005-7. J Clin Pathol. 2008; 62(1):26-30. PMC: 2603283. DOI: 10.1136/jcp.2008.058859. View

5.
Streetly A, Clarke M, Downing M, Farrar L, Foo Y, Hall K . Implementation of the newborn screening programme for sickle cell disease in England: results for 2003-2005. J Med Screen. 2008; 15(1):9-13. DOI: 10.1258/jms.2008.007063. View